Release Therapeutics
Empowering Lives with Unique CNS-directed Therapeutics
Release Therapeutics is developing breakthrough cell encapsulation technology to deliver therapeutic proteins to the brain, with its lead program targeting Metachromatic Leukodystrophy (MLD), a rare genetic disorder affecting young children
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
No news
No milestones
No Jobs
No videos and documents
No Awards
Release Therapeutics
Empowering Lives with Unique CNS-directed Therapeutics
Website:
www.release-tx.com/
Headquarter:
Geneva
Foundation Date:
February 2016
Technology:
- Medtech